1. Starbucks (SBUX)
 |
| SBUX |
Starbucks is one of the stocks where sales can recover as vaccines are developed. There are several notable factors for Starbucks' competitiveness. Starbucks managed to offset some of the pandemic hits with drive-through operations and order processing through a digital platform. When economic activity returns to normal, its new and existing store sales growth can lead to double-digit revenue growth, and investors optimistic about the economic recovery should consider buying stock before doing so.
 |
SBUX stock price |
2. Walmart (WMT)
 |
| WMT |
Walmart is a large retailer with more than 500,000 new employees in 2020 and plans to employ more than 20,000 short term workers in e-commerce fulfillment centers. Our aggressive hiring plans are an indicator of sales that will grow significantly in the future. Of course, Walmart's strongest rival is Amazon. Nevertheless, Walmart has both digital and store-selling products that can compete with Amazon, and in this regard, it has a comparative advantage. Walmart's investment in store pickup and delivery has made it possible to provide good service even during the pandemic, and if people continue to shop non-face-to-face, they will continue to invest after the pandemic.
 |
| WMT stock price |
3. Chevron Corp. (CVX)
 |
| CVX |
The energy sector has been one of the biggest beneficiaries of the recent stock market craze for vaccines. If the economy normalizes, I think the demand for oil for travel and transportation of goods, as well as the sales of oil producing companies, will increase. Chevron was in a state of operating cost savings, but retained its existing dividend and now has a market dividend of 6%. Chevron completed the acquisition of Noble Energy in October and paid a premium for Noble's share price somewhat higher than the low of Noble's share price this year. It demonstrates a strong market position.
 |
| CVX stock price |
Comments
Post a Comment